Lipidomic signature of stroke recurrence after transient ischemic attack.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
22 08 2023
22 08 2023
Historique:
received:
27
12
2022
accepted:
17
08
2023
medline:
24
8
2023
pubmed:
23
8
2023
entrez:
22
8
2023
Statut:
epublish
Résumé
While TIA patients have transient symptoms, they should not be underestimated, as they could have an underlying pathology that may lead to a subsequent stroke: stroke recurrence (SR). Previously, it has been described the involvement of lipids in different vascular diseases. The aim of the current study was to perform a lipidomic analysis to identify differences in the lipidomic profile between patients with SR and patients without. Untargeted lipidomic analysis was performed in plasma samples of 460 consecutive TIA patients recruited < 24 h after the onset of symptoms. 37 (8%) patients suffered SR at 90 days. Lipidomic profiling disclosed 7 lipid species differentially expressed between groups: 5 triacylglycerides (TG), 1 diacylglyceride (DG), and 1 alkenyl-PE (plasmalogen) [specifically, TG(56:1), TG(63:0), TG(58:2), TG(50:5), TG(53:7, DG(38:5)) and PE(P-18:0/18:2)]. 6 of these 7 lipid species belonged to the glycerolipid family and a plasmalogen, pointing to bioenergetics pathways, as well as oxidative stress response. In this context, it was proposed the PE(P-18:0/18:2) as potential biomarker of SR condition.The observed changes in lipid patterns suggest pathophysiological mechanisms associated with lipid droplets metabolism and antioxidant protection that is translated to plasma level as consequence of a more intensive or high-risk ischemic condition related to SR.
Identifiants
pubmed: 37607967
doi: 10.1038/s41598-023-40838-7
pii: 10.1038/s41598-023-40838-7
pmc: PMC10444771
doi:
Substances chimiques
Lipids
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
13706Informations de copyright
© 2023. Springer Nature Limited.
Références
Virani, S. S. et al. Heart disease and stroke statistics-2020 update: A report from the American heart association. Circulation 141, e139–e596. https://doi.org/10.1161/CIR.0000000000000757 (2020).
doi: 10.1161/CIR.0000000000000757
pubmed: 31992061
Purroy, F. & Montala, N. Epidemiology of stroke in the last decade: a systematic review. Rev. Neurol. 73, 321–336. https://doi.org/10.33588/rn.7309.2021138 (2021).
doi: 10.33588/rn.7309.2021138
pubmed: 34676530
Albers, G. W. et al. Transient ischemic attack–proposal for a new definition. N. Engl. J. Med. 347, 1713–1716. https://doi.org/10.1056/NEJMsb020987 (2002).
doi: 10.1056/NEJMsb020987
pubmed: 12444191
Valls, J. et al. A current estimation of the early risk of stroke after transient ischemic attack: A systematic review and meta-analysis of recent intervention studies. Cerebrovasc. Dis. 43, 90–98. https://doi.org/10.1159/000452978 (2017).
doi: 10.1159/000452978
pubmed: 27992865
Shahjouei, S. et al. A 5-decade analysis of incidence trends of ischemic stroke after transient ischemic attack: A systematic review and meta-analysis. JAMA Neurol. 78, 77–87. https://doi.org/10.1001/jamaneurol.2020.3627 (2021).
doi: 10.1001/jamaneurol.2020.3627
pubmed: 33044505
Purroy, F. et al. Sex-related differences in clinical features, neuroimaging, and long-term prognosis after transient ischemic attack. Stroke; J. Cereb. Circ. 52, 424–433. https://doi.org/10.1161/STROKEAHA.120.032814 (2021).
doi: 10.1161/STROKEAHA.120.032814
Purroy, F. et al. Patterns of diffusion-weighted magnetic resonance imaging associated with etiology improve the accuracy of prognosis after transient ischaemic attack. Eur. J. Neurol. 18, 121–128. https://doi.org/10.1111/j.1468-1331.2010.03080.x (2011).
doi: 10.1111/j.1468-1331.2010.03080.x
pubmed: 20500525
Ois, A. et al. Factors associated with a high risk of recurrence in patients with transient ischemic attack or minor stroke. Stroke 39, 1717–1721 (2008).
doi: 10.1161/STROKEAHA.107.505438
pubmed: 18369168
Amarenco, P. et al. Five-year risk of stroke after TIA or minor ischemic stroke. N. Engl. J. Med. 378, 2182–2190. https://doi.org/10.1056/NEJMoa1802712 (2018).
doi: 10.1056/NEJMoa1802712
pubmed: 29766771
Purroy, F. et al. Recurrent transient ischaemic attack and early risk of stroke: data from the PROMAPA study. J. Neurol. Neurosurg. Psychiatry 84, 596–603. https://doi.org/10.1136/jnnp-2012-304005 (2013).
doi: 10.1136/jnnp-2012-304005
pubmed: 23345284
Nouri-Vaskeh, M., Khalili, N., Sadighi, A., Yazdani, Y. & Zand, R. Biomarkers for transient ischemic attack: A brief perspective of current reports and future horizons. J. Clin. Med. 11, 1046. https://doi.org/10.3390/jcm11041046 (2022).
doi: 10.3390/jcm11041046
pubmed: 35207321
pmcid: 8877275
Jove, M. et al. Metabolomics predicts stroke recurrence after transient ischemic attack. Neurology 84, 36–45. https://doi.org/10.1212/WNL.0000000000001093 (2015).
doi: 10.1212/WNL.0000000000001093
pubmed: 25471397
pmcid: 4336096
Montero-Bullon, J. F. et al. Cardiac phospholipidome is altered during ischemia and reperfusion in an ex vivo rat model. Biochem. Biophys. Rep. 27, 101037. https://doi.org/10.1016/j.bbrep.2021.101037 (2021).
doi: 10.1016/j.bbrep.2021.101037
pubmed: 34169155
pmcid: 8207217
Au, A. Metabolomics and lipidomics of ischemic stroke. Adv. Clin. Chem. 85, 31–69. https://doi.org/10.1016/bs.acc.2018.02.002 (2018).
doi: 10.1016/bs.acc.2018.02.002
pubmed: 29655461
Campbell, B. C. V. et al. Ischaemic stroke. Nat. Rev. Dis. Primers 5, 70. https://doi.org/10.1038/s41572-019-0118-8 (2019).
doi: 10.1038/s41572-019-0118-8
pubmed: 31601801
Dean, J. M. & Lodhi, I. J. Structural and functional roles of ether lipids. Protein Cell 9, 196–206. https://doi.org/10.1007/s13238-017-0423-5 (2018).
doi: 10.1007/s13238-017-0423-5
pubmed: 28523433
Zheng, L. et al. An imbalanced ratio between PC(16:0/16:0) and LPC(16:0) revealed by lipidomics supports the role of the Lands cycle in ischemic brain injury. J. Biol. Chem. 296, 100151. https://doi.org/10.1074/jbc.RA120.016565 (2021).
doi: 10.1074/jbc.RA120.016565
pubmed: 33288676
Pradas, I. et al. Exceptional human longevity is associated with a specific plasma phenotype of ether lipids. Redox Biol. 21, 101127. https://doi.org/10.1016/j.redox.2019.101127 (2019).
doi: 10.1016/j.redox.2019.101127
pubmed: 30711699
pmcid: 6357979
Sastry, P. S. Lipids of nervous tissue: Composition and metabolism. Prog. Lipid. Res. 24, 69–176. https://doi.org/10.1016/0163-7827(85)90011-6 (1985).
doi: 10.1016/0163-7827(85)90011-6
pubmed: 3916238
Jove, M. et al. New insights into human prefrontal cortex aging with a lipidomics approach. Expert Rev. Proteomics 18, 333–344. https://doi.org/10.1080/14789450.2021.1940142 (2021).
doi: 10.1080/14789450.2021.1940142
pubmed: 34098823
Bartz, R. et al. Lipidomics reveals that adiposomes store ether lipids and mediate phospholipid traffic. J. Lipid. Res. 48, 837–847. https://doi.org/10.1194/jlr.M600413-JLR200 (2007).
doi: 10.1194/jlr.M600413-JLR200
pubmed: 17210984
Smolic, T. et al. Astrocytes in stress accumulate lipid droplets. Glia 69, 1540–1562. https://doi.org/10.1002/glia.23978 (2021).
doi: 10.1002/glia.23978
pubmed: 33609060
pmcid: 8248329
Jove, M. et al. Ether lipid-mediated antioxidant defense in Alzheimer’s disease. Antioxidants (Basel) 12, 293. https://doi.org/10.3390/antiox12020293 (2023).
doi: 10.3390/antiox12020293
pubmed: 36829852
Lonati, E. et al. Lipid reshaping and lipophagy are induced in a modeled ischemia-reperfusion injury of blood brain barrier. Int. J. Mol. Sci. 20, 3752. https://doi.org/10.3390/ijms20153752 (2019).
doi: 10.3390/ijms20153752
pubmed: 31370282
pmcid: 6696511
Wang, X. et al. Changes of metabolites in acute ischemic stroke and its subtypes. Front. Neurosci. 14, 580929. https://doi.org/10.3389/fnins.2020.580929 (2020).
doi: 10.3389/fnins.2020.580929
pubmed: 33505234
Sun, D. et al. A prospective study of serum metabolites and risk of ischemic stroke. Neurology 92, e1890–e1898. https://doi.org/10.1212/WNL.0000000000007279 (2019).
doi: 10.1212/WNL.0000000000007279
pubmed: 30867269
pmcid: 6550501
Liu, P. et al. Discovery of metabolite biomarkers for acute ischemic stroke progression. J. Proteome Res. 16, 773–779. https://doi.org/10.1021/acs.jproteome.6b00779 (2017).
doi: 10.1021/acs.jproteome.6b00779
pubmed: 28092160
Jiang, Z. et al. A metabonomic approach applied to predict patients with cerebral infarction. Talanta 84, 298–304. https://doi.org/10.1016/j.talanta.2011.01.015 (2011).
doi: 10.1016/j.talanta.2011.01.015
pubmed: 21376948
Davis Armstrong, N. M. et al. Multi-omic analysis of stroke recurrence in African Americans from the vitamin intervention for stroke prevention (VISP) clinical trial. PLoS ONE 16, e0247257. https://doi.org/10.1371/journal.pone.0247257 (2021).
doi: 10.1371/journal.pone.0247257
pubmed: 33661917
pmcid: 7932724
Turner, R. J. & Sharp, F. R. Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke. Front. Cell Neurosci. 10, 56. https://doi.org/10.3389/fncel.2016.00056 (2016).
doi: 10.3389/fncel.2016.00056
pubmed: 26973468
pmcid: 4777722
Sonderer, J. & Katan Kahles, M. Aetiological blood biomarkers of ischaemic stroke. Swiss Med. Wkly 145, w14138. https://doi.org/10.4414/smw.2015.14138 (2015).
doi: 10.4414/smw.2015.14138
pubmed: 26024210
Valls, J. et al. A current estimation of the early risk of stroke after Ttansient ischemic attack: A systematic review and meta-analysis of recent intervention studies. Cerebrovasc. Dis. 43, 90–98. https://doi.org/10.1159/000452978 (2017).
doi: 10.1159/000452978
pubmed: 27992865
Rothwell, P. M. et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet 366, 29–36 (2005).
doi: 10.1016/S0140-6736(05)66702-5
pubmed: 15993230
Purroy, F. et al. Patterns and predictors of early risk of recurrence after transient ischemic attack with respect to etiologic subtypes. Stroke; J. Cereb. Circ. 38, 3225–3229. https://doi.org/10.1161/STROKEAHA.107.488833 (2007).
doi: 10.1161/STROKEAHA.107.488833
Ois, A. et al. Long-term cardiovascular prognosis after transient ischemic attack: Associated predictors. Neurology 90, e553–e558. https://doi.org/10.1212/WNL.0000000000004965 (2018).
doi: 10.1212/WNL.0000000000004965
pubmed: 29343466
von Elm, E. et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 370, 1453–1457. https://doi.org/10.1016/S0140-6736(07)61602-X (2007).
doi: 10.1016/S0140-6736(07)61602-X
Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 21, 637–676 (1990).
Ohman, E. M. et al. The REduction of atherothrombosis for continued health (REACH) registry: An international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am. Heart J. 151, 786.e1-786.e10. https://doi.org/10.1016/j.ahj.2005.11.004 (2006).
doi: 10.1016/j.ahj.2005.11.004
pubmed: 16569533
Ay, H. et al. An evidence-based causative classification system for acute ischemic stroke. Ann. Neurol. 58, 688–697. https://doi.org/10.1002/ana.20617 (2005).
doi: 10.1002/ana.20617
pubmed: 16240340
Herve, D., Gautier-Bertrand, M., Labreuche, J., Amarenco, P. & Investigators, G. Predictive values of lacunar transient ischemic attacks. Stroke 35, 1430–1435. https://doi.org/10.1161/01.STR.0000127365.49448.0f (2004).
doi: 10.1161/01.STR.0000127365.49448.0f
pubmed: 15118181
Pizarro, C., Arenzana-Rámila, I., Pérez-del-Notario, N., Pérez-Matute, P. & González-Sáiz, J. M. Plasma lipidomic profiling method based on ultrasound extraction and liquid chromatography mass spectrometry. Anal. Chem. 85, 12085–12092. https://doi.org/10.1021/ac403181c (2013).
doi: 10.1021/ac403181c
pubmed: 24266777
Want, E. J. et al. Global metabolic profiling of animal and human tissues via UPLC-MS. Nat. Protoc. 8, 17–32. https://doi.org/10.1038/nprot.2012.135 (2013).
doi: 10.1038/nprot.2012.135
pubmed: 23222455
Pradas, I. et al. Lipidomics reveals a tissue-specific fingerprint. Front. Physiol. 9, 1165. https://doi.org/10.3389/fphys.2018.01165 (2018).
doi: 10.3389/fphys.2018.01165
pubmed: 30210358
pmcid: 6121266
Castro-Perez, J. M. et al. Comprehensive LC-MS E lipidomic analysis using a shotgun approach and its application to biomarker detection and identification in osteoarthritis patients. J. Proteome Res. 9, 2377–2389. https://doi.org/10.1021/pr901094j (2010).
doi: 10.1021/pr901094j
pubmed: 20355720
Dunn, W. B. et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 6, 1060–1083. https://doi.org/10.1038/nprot.2011.335 (2011).
doi: 10.1038/nprot.2011.335
pubmed: 21720319
Sana, T. R., Roark, J. C., Li, X., Waddell, K. & Fischer, S. M. Molecular formula and METLIN personal metabolite database matching applied to the identification of compounds generated by LC/TOF-MS. J. Biomol. Tech. 19, 258–266 (2008).
pubmed: 19137116
pmcid: 2567134
Wishart, D. S. et al. HMDB: A knowledgebase for the human metabolome. Nucleic Acids Res. 37, D603-610. https://doi.org/10.1093/nar/gkn810 (2009).
doi: 10.1093/nar/gkn810
pubmed: 18953024
Koelmel, J. P. et al. LipidMatch: an automated workflow for rule-based lipid identification using untargeted high-resolution tandem mass spectrometry data. BMC Bioinf. 18, 331. https://doi.org/10.1186/s12859-017-1744-3 (2017).
doi: 10.1186/s12859-017-1744-3
Xia, J., Sinelnikov, I. V., Han, B. & Wishart, D. S. MetaboAnalyst 3.0–making metabolomics more meaningful. Nucleic Acids Res. 43, W251-257. https://doi.org/10.1093/nar/gkv380 (2015).
doi: 10.1093/nar/gkv380
pubmed: 25897128
pmcid: 4489235